Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS Consortium
David R. Shaw(National Centre for Atmospheric Science), David Litt(UK Health Security Agency), Ala‐Eddine Deghmane(Institut Pasteur), Jillian Johnston, Helga Erlendsdóttir(National University Hospital of Iceland), Kurt Fuursted(Statens Serum Institut), Robert Cunney(Beaumont Hospital), Raquel Abad(Instituto de Salud Carlos III), Margaret Ip(Chinese University of Hong Kong), Richard J. Drew(Royal College of Surgeons in Ireland), Carlo Casanova(University of Bern), Linda de Gouveia(National Health Laboratory Service), Yiu-Wai Chu(Department of Health), Juliana Coelho(Public Health England), Karl G. Kristinsson(National University Hospital of Iceland), Markus Hilty(University of Bern), Thiên‐Trí Lâm(University of Würzburg), Birgitta Henriques‐Normark(Karolinska University Hospital), Mirian Domenech(Centro de Investigación Biomédica en Red de Enfermedades Respiratorias), Keith A. Jolley(University of Oxford), Thomas Hale(University of Oxford), Shamez Ladhani(Public Health England), Pavla Křížová(National Institute of Public Health), Désirée E. Bennett(Beaumont Hospital), Alicja Kuch(Narodowy Instytut Leków), Desirée Henares(Hospital Sant Joan de Déu Barcelona), Heather Davies(New Zealand Institute for Public Health and Forensic Science), Karen Broughton(Public Health England), Norman K. Fry(Public Health England), Lize Cuypers(KU Leuven), Mignon du Plessis(National Health Laboratory Service), Tine Dalby(Statens Serum Institut), Mary Corcoran(Children's Health Ireland at Crumlin), Zahin Amin‐Chowdhury(Public Health England), Eun Hwa Choi(Seoul National University), Steen Hoffmann(Statens Serum Institut), María Eugenia León(Ministerio de Salud Pública y Bienestar Social), H. Humphreys(Beaumont Hospital), Carolina Duarte(Instituto Nacional de Salud), Aníbal Kawabata(Ministerio de Salud Pública y Bienestar Social), Simon Cottrell(Public Health Wales), Walter Demczuk(Public Health Agency of Canada), Bin Cao(Shandong Provincial Hospital), Christopher R. Johnson(Public Health Wales), Jana Kozáková(National Institute of Public Health), Susanne Jacobsson(Örebro University), Stefanie Desmet(KU Leuven), Laura Lindholm(Finnish Institute for Health and Welfare), Heike Claus(University of Würzburg)
Cited by 157
Related Papers
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
|The Lancet|2020|51.8k
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
|The Lancet|2020|29.1k
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
|New England Journal of Medicine|2020|5.5k
A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker)
|Nature Human Behaviour|2021|4.7k